A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma

Clinical trial NCT00199342 · TERMINATED

Trial details

NCT number: NCT00199342
Sponsor: Kyowa Kirin, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage IV Melanoma

Start date: 2004-11-01
Primary completion: 2005-10-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.